Concordance of Pain Detection in Patients by Doloplus® and Algoplus® Behavioural Scales
CALDOL
1 other identifier
observational
210
1 country
1
Brief Summary
The pain of the elderly is often trivialized and ignored in spite of its high frequency: the chronic pain affects 50 % of the elderly living at home, 49 to 83 % of those living in institution and 80 % of this population at the end of life. The evaluation of pain appeals to the same strategy as to the younger subject but with some specificities, related more to the pathologies associated with the ageing than to the real age. For that purpose, the investigators have self-assessment scales as the Numeric Pain Rating Scale which is adapted to estimate acute and chronic pains, but this scale presents a bias because, some patients do not express spontaneously their pain. So behavioural scales were elaborated to solve the difficulties of detection and to care the pain of the elderly. The Algoplus® scale (5 items which takes less than one minute to be completed) whose objective is the observation of behavioural changes caused by the acute pain in elderly having communication disorders. The Doloplus® scale (30 items which allow in few minutes a good evaluation of pain) whose objective is the observation of behavioural changes caused by the chronic pain in elderly having communication impairments. In practice, because of its popularity, the Algoplus® scale is widely used out of the specificity in which it has been validated. Practitioners, worried about this misuse, suggested to Doloplus® group, to test the concordance between the two behavioural scales in order to develop recommendations more targeted. The risk is that the use of the Algoplus® scale may underestimate pain that would have been detected by Doloplus® scale, and lead to under-treatment or non-treatment of pain in elderly having communication disorders. This study aims to establish the concordance between these two scales to generate advices and recommendations to assess efficiently the pain in this vulnerable population. The main objective of this study is to assess whether the use of Algoplus® scale is in good concordance with Doloplus® scale. The secondary objective of this study is to assess the concordance with different levels of Algoplus® pain scale: (0-1), (2-3), (4-5).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 23, 2014
CompletedFirst Posted
Study publicly available on registry
June 26, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedJune 26, 2014
June 1, 2014
6 months
May 23, 2014
June 23, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain scores on Algoplus® and Doloplus® pain scales
at 48 hours after patients' admission in the care service.
Secondary Outcomes (1)
Different levels of Algoplus® pain scale: (0-1), (2-3), (4-5)
at 48 hours after patients' admission in the care service.
Study Arms (1)
numerical scale
Interventions
Eligibility Criteria
elderly patients
You may qualify if:
- Patients of 65 or more years old
- Patients having communication disorders
- Hospitalization for at least 48 hours
You may not qualify if:
- Patients of less than 65 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Clermont-Ferrandlead
- Dr. Gisèle PICKERING (MCU, PH) Center of clinical pharmacology/CIC Inserm-1405 - Main investigator - Coordinating centercollaborator
- Ms Joëlle DEVOT - Collaboratorcollaborator
- Dr Patrice RAT - Investigatorcollaborator
- Dr Chandra COLOM - Investigatorcollaborator
- Mr Dieudonné ENDOUGOU - Collaboratorcollaborator
- Dr Cyril GUILLAUME - Investigatorcollaborator
- Ms Nathalie ROUX - Collaboratorcollaborator
- Dr Yves PASSADORI - Investigatorcollaborator
- Ms Nathalie DANNENBERGER - Collaboratorcollaborator
- Dr Micheline MICHEL - Investigatorcollaborator
- Dr Sylvie CHAPIRO- Investigatorcollaborator
- Dr Jean-François VILLARD - Investigatorcollaborator
- Dr Bernard WARY- Investigatorcollaborator
- Dr Anne-Cécile BOURJAL - Investigatorcollaborator
- Dr Catherine BLUNTZ - Investigatorcollaborator
- Dr Françoise CAPRIZ - Investigatorcollaborator
- Dr Marie FLOCCIA - Investigatorcollaborator
- Dr Jérôme BOHATIER - Investigatorcollaborator
- Ms Linh NGUYEN PHUONG - Collaboratorcollaborator
Study Sites (1)
CHU Clermont-Ferrand
Clermont-Ferrand, 63003, France
Study Officials
- PRINCIPAL INVESTIGATOR
Gisèle PICKERING
University Hospital, Clermont-Ferrand
Central Study Contacts
Study Design
- Study Type
- observational
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2014
First Posted
June 26, 2014
Study Start
January 1, 2014
Primary Completion
July 1, 2014
Study Completion
September 1, 2014
Last Updated
June 26, 2014
Record last verified: 2014-06